Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 33 member 2 (SLC33A2, MFSD3) is a protein classified as a putative membrane-bound transporter belonging to the major facilitator superfamily (MFS), often termed an "atypical SLC" due to its sequence similarity to other SLCs but its orphan status regarding substrate specificity, mechanism, and physiological role[1][2]. MFSD3 shares evolutionary origin and sequence identity with SLC33A1 (the acetyl-CoA transporter), suggesting it may transport organic molecules, potentially acetyl-CoA, but its substrates and cellular roles remain to be elucidated[1]. The gene is expressed broadly in neurons and responsive to metabolic changes, hinting at possible involvement in regulation of energy homeostasis or metabolic adaptation, though direct functional and disease associations are unconfirmed at present[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 33 member 2 (SLC33A2).